Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 357 | $6.446 | $2,301 | 64,027 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 801 | $6.446 | $5,163 | 235,255 (Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 767 | $6.446 | $4,944 | 573,628 (Indirect Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 2,253 | $6.446 | $14,523 | 1,193,044 (Indirect Direct) | View |
| 2025-05-20 Sale | 2025-05-22 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 587 | $6.446 | $3,784 | 149,163 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 655 | $6.528 | $4,276 | 64,384 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 1,409 | $6.528 | $9,198 | 574,395 (Indirect Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 1,582 | $6.528 | $10,327 | 236,056 (Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 3,621 | $6.528 | $23,638 | 1,195,297 (Indirect Direct) | View |
| 2025-05-16 Sale | 2025-05-20 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 946 | $6.528 | $6,175 | 149,750 (Direct) | View |
| 2025-04-22 Sale | 2025-04-24 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 718 | $7.158 | $5,139 | 65,039 (Direct) | View |
| 2025-04-10 Purchase | 2025-04-14 6:57 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 20,000 | $5.08 | $101,600 | 1,198,918 (Indirect Direct) | View |
| 2025-04-09 Purchase | 2025-04-10 4:07 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 21,099 | $4.7 | $99,165 | 575,804 (Indirect Direct) | View |
| 2025-04-04 Sale | 2025-04-08 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer | 7,489 | $5.294 | $39,647 | 129,650 (Direct) | View |
| 2024-05-17 Sale | 2025-02-27 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 15,093 | $14.84 | $223,965 | 237,638 (Direct) | View |
| 2025-02-21 Sale | 2025-02-25 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 6,078 | $10.58 | $64,305 | 554,705 (Indirect Direct) | View |
| 2025-02-21 Sale | 2025-02-25 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 3,222 | $10.58 | $34,089 | 150,696 (Direct) | View |
| 2025-02-21 Sale | 2025-02-25 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 2,737 | $10.58 | $28,957 | 65,757 (Direct) | View |
| 2025-02-21 Sale | 2025-02-25 4:01 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 16,303 | $10.58 | $172,486 | 1,178,918 (Indirect Direct) | View |
| 2025-01-23 Sale | 2025-01-27 4:16 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 896 | $10.38 | $9,300 | 48,414 (Direct) | View |
| 2024-11-21 Sale | 2024-11-25 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 1,224 | $13.05 | $15,978 | 49,310 (Direct) | View |
| 2024-11-21 Sale | 2024-11-25 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 4,588 | $13.05 | $59,892 | 502,997 (Indirect Direct) | View |
| 2024-11-21 Sale | 2024-11-25 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 11,091 | $13.05 | $144,782 | 1,113,566 (Indirect Direct) | View |
| 2024-11-21 Sale | 2024-11-25 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 1,175 | $13.05 | $15,338 | 63,560 (Direct) | View |
| 2024-10-31 Sale | 2024-11-04 4:06 pm | ROCKET PHARMACEUTICALS INC. | RCKT | White Mark Andrew See Remarks | 3,080 | $16.63 | $51,205 | 69,140 (Direct) | View |
| 2024-10-31 Sale | 2024-11-04 4:05 pm | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 917 | $16.63 | $15,245 | 50,534 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-05 Other | 2025-04-24 4:06 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director | 14,220 | $0 | 28,440 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2035-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Wilson Martin General Counsel | 225,000 | $0 | 288,560 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2035-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Shah Gaurav CEO | 325,000 | $0 | 1,438,566 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2025-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Schwartz Jonathan David See Remarks | 200,000 | $0 | 372,413 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2035-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Patel Kinnari See Remarks | 230,000 | $0 | 732,997 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2035-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Ondrey Aaron Chief Financial Officer | 225,000 | $0 | 271,781 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-13 4:01 pm | N/A 2035-02-11 | ROCKET PHARMACEUTICALS INC. | RCKT | Militello John See Remarks | 50,000 | $0 | 98,414 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-05 7:47 pm | N/A 2035-02-03 | ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director | 73,624 | $0 | 73,624 (Direct) | View |
Ownership | 2025-02-05 7:43 pm | 2020-08-03 2030-08-03 | ROCKET PHARMACEUTICALS INC. | RCKT | Pratumsuwan Piratip Director | 0 | $0 | 20,000 (Direct) | View |
| 2024-12-12 Option Award | 2024-12-16 7:38 pm | N/A N/A | ROCKET PHARMACEUTICALS INC. | RCKT | RTW INVESTMENTS LP WONG RODERICK See remarks 10% Owner | 400,000 | $12.49 | 3,526,955 (Indirect) | View |
| 2024-09-26 Option Award | 2024-10-29 5:05 pm | N/A 2034-09-26 | ROCKET PHARMACEUTICALS INC. | RCKT | Bjork Elisabeth Director | 607 | $0 | 607 (Direct) | View |
| 2024-09-26 Option Award | 2024-10-29 4:58 pm | N/A 2034-09-26 | ROCKET PHARMACEUTICALS INC. | RCKT | Makker Gotham Director | 507 | $0 | 507 (Direct) | View |
| 2024-09-09 Option Award | 2024-09-11 4:07 pm | N/A 2034-09-09 | ROCKET PHARMACEUTICALS INC. | RCKT | Dolsten Mikael Director | 50,533 | $0 | 50,533 (Direct) | View |